Best of ASCO - 2014 Annual Meeting

 

Welcome

Geriatric Oncology

Patient and Survivor Care

2018 ASCO Annual Meeting

Sort by: title abstract no. first author
ABSTRACT TITLEFIRST AUTHORABSTRACT NO.
An integrated medical oncology-psychiatry practice model improves overall patient functionality of prostate cancer patients by identifying, quantifying and treating the pre-existing non-cancer co-morbidities.

Lisa Marie Ruppert

e22051

Analysis of feasibility of geriatric assessment tools in elderly cancer patients and effects on anti-cancer treatment planning.

Ulug Mutlu Gunaydin

e22028

Anti-PD1 antibodies in late elderly advanced melanoma patients: A retrospective multicentre study.

Francesco De Rosa

10038

Association between participation in religious activities and depression and anxiety in older patients with cancer.

Yu Cao

10044

Association of comorbidity and polypharmacy with skeletal muscle measures in older adults with cancer.

Grant Richard Williams

e22029

Association of financial toxicity (FT) with depression, anxiety, and quality of life (QoL) in older patients with advanced cancer: An analysis of 544 patients from 31 practices in the University of Rochester NCI Community Oncology Research Program (UR NCORP).

Asad Arastu

e22037

Associations of medication measures and geriatric impairments with chemotherapy dose intensity in older adults with advanced cancer: A University of Rochester NCI Community Oncology Research Program study.

Mostafa R. Mohamed

e22034

Breast Cancer in nonagenarians: Single institutional experience in development country.

Daniele Neves

e22032

Chemotherapy in nonagenarians palliative care: Single institutional experience in development country.

Juliana Souza

e22016

Colorectal surgery in the elderly: Does the extreme age determine the odds ratio of complications?

Gemma Soler

e22046

Development and temporal validation of a practical prognostic scoring system (ONCOGERIATRIC INDEX -OGI) based on the comprehensive geriatric assessment to predict early death in elderly cancer patients: A 892 patients cohort study.

Jurema Telles O Lima

10049

Differences in chemotherapy-induced neuropathy (CIN) among younger and older cancer survivors.

Melisa L. Wong

e22022

Disparities in healthcare communication in the context of advanced cancer: Black vs. white older patients and social determinants of health.

Charles Stewart Kamen

e22025

Examining progression free survival (PFS), overall survival (OS), and toxicities of palbociclib in a geriatric population.

Katherine Clifton

10039

Feasibility and implementation of geriatric assessment measures and patient-reported outcomes in a phase 1 trial for acute myeloid leukemia.

Heidi D. Klepin

e22040

Feasibility of implementing the G8 screening tool in geriatric patients in oncology clinics across multiple institutions.

Rashida Haq

e22026

Geriatric assessment (GA) and treatment (Tx) outcomes in older adults with cancer receiving immunotherapy (IO).

Karim Welaya

e22023

Geriatric assessment (GA) reporting in real time in non-elective hospitalized older cancer patients.

Trevor Augustus Jolly

e22045

Geriatric assessment to predict hospitalization frequency and long-term care utilization in older adult cancer survivors.

Grant Richard Williams

10036

Geriatric comanagement and surgical outcomes of older cancer patients.

Armin Shahrokni

10035

Geriatric oncology - lung adenocarcinoma in elderly patients undergoing systemic palliative treatment: Prospective analysis of clinical characteristics and survival outcomes.

Mauro Daniel Spina Donadio

e22027

Impact of age on outcomes with PD-(L)1 blockade in patients (Pts) with non-small cell lung cancer (NSCLC).

Morgan Lichtenstein

10040

Impact of patient reported functional limitation on overall survival in older adults undergoing autologous hematopoietic cell transplant (AutoHCT).

Mariam T. Nawas

10030

Improving communication with older patients with cancer using geriatric assessment (GA): A University of Rochester NCI Community Oncology Research Program (NCORP) cluster randomized controlled trial (CRCT).

Supriya Gupta Mohile

LBA10003

Inflamm-aging and the need to consider age in cytokine-patient-reported outcome (PRO) relationships: The case of acute myeloid leukemia (AML).

Shabbir M.H. Alibhai

10047

Is there a role for immunotherapy (IO) and tyrosine kinase inhibitors (TKI) for older adults with metastatic renal cell carcinoma (mRCC)?

Nazli Dizman

e22052

Is there a role for older-patient-specific cancer clinical trials? A pooled analysis of 2277 older patients in adjuvant breast cancer trials (Alliance A151715).

Dyda Dao

10034

Malnutrition and overall survival in older patients with cancer.

Xiaotao Zhang

e22015

Metastatic renal cell carcinoma in the elderly: A single Irish institution experience.

Jane Sze Yin Sui

e22048

Octogenarians with colorectal cancer: Clinical characteristics and therapy in a single institution experience.

Elizabeth Inga Saavedra

e22036

Oncogeriatric screening in patients with colorectal cancer: Is it a good tool for making decisions about their treatment?

Gemma Soler

e22049

Patient-defined goals and preferences among older adults with cancer starting chemotherapy (CT).

Enrique Soto Perez De Celis

10009

Patient-reported psychosocial needs and psychological distress: the influence on survival in geriatric oncology patients.

Bonnie Leung

10033

Phase 2 randomized study of a walking intervention for radiation-related fatigue among older breast cancer patients receiving radiation.

Noam Avraham VanderWalde

10037

Phase II trial of S-1 and concurrent radiotherapy (RT) in elderly patients (pts) with esophageal squamous cell carcinoma (ESCC).

Tao Song

e22018

Predicting chemotherapy toxicity and death in older adults with colon cancer: Results of MOST (Massilia Oncologic Senior Tests) study.

Frédérique Retornaz

10041

Prediction of chemotherapy related toxicities in older Asian adults with cancer.

Angela Pang

e22021

Predictors of chemotherapy modification at first cycle in elderly patient.

Jaime Feliu Batlle

e22019

Prevalence and clinical correlates of vulnerable status using the Vulnerable Elders Survey 13 (VES-13) in newly diagnosed adult non-Hodgkin lymphoma (NHL) patients: A LEO cross-sectional analysis.

Angelo Fama

10042

Prognostic benefit of taking statin and/or metformin in elderly patients with advanced non-small cell lung cancer: A nationwide population-based epidemiologic study.

Yun-Gyoo Lee

10045

Quality of life (QoL) in older patients (pts) with cancer and prognostic factors for QoL decline.

Lore Decoster

10010

Quality of life as a predictor of early death in older cancer patients: A prospective cohort study.

Jurema Telles O Lima

e22017

Randomized clinical trial of telephoned-based physical activity intervention in onco-geriatric patients.

Haritz Arrieta

10031

Randomized trial of a pharmacy intervention for older adults with cancer.

Margaret Ruddy

10012

Relationship between preoperative geriatric frailty and need for postoperative intensive care unit admission and subsequent short- and long-term mortality.

Armin Shahrokni

10011

Stepping On: Cancer Edition: A fall-prevention intervention adapted for older adults with cancer.

Tanya Marya Wildes

e22020

Survival and predictive factors related to comprehensive geriatric assessment for the occurrence of healthcare-associated infections (HAI): A cohort study with elderly cancer patients.

Guacyra Magalhaes Pires

e22053

Symptom assessment of oldest old cancer patients.

Linda Pang

e22035

The approach of community oncology providers towards pre-treatment assessment of older patients with metastatic breast cancer (MBC).

Efrat Dotan

e22043

The effect of a geriatric oncology (GO) evaluation on treatment (Tx) decisions for older patients (pts) with cancer in Mexico.

Haydee Cristina Verduzco-Aguirre

10046

The impact of a positive cognitive impairment screen on conversations between patients, caregivers, and oncologists: A UR NCORP randomized study.

Allison Magnuson

10048

The utility of a modified frailty index in predicting chemotherapy toxicity, response and survival for older patients (pts) with advanced pancreatic cancer receiving first-line palliative chemotherapy: A single institution experience.

Hanbo Zhang

e22030

The value of inflammatory markers in predicting overall survival in older adults with cancer.

Tomohiro F. Nishijima

10032

Use of a chemotherapy toxicity prediction tool to decrease the risks for hospitalization in the elderly.

Mintcho Elinov Mintchev

e22047

Using a geriatric oncology assessment to link with services in an underserved, community oncology population.

Leah L. Zullig

e22024

Utilizing a practical tablet-based modified geriatric assessment in clinic for older adults with multiple myeloma (MM).

Nitya Nathwani

10043

Vitamin D deficiency in older cancer patients with solid tumors, effect on overall survival.

Beatrice Jara-Almonte Edwards

e22038